Bailard’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-897
Closed -$249K 798
2022
Q3
$249K Buy
+897
New +$228K 0.01% 513
2021
Q1
Sell
-9,900
Closed -$1.03M 745
2020
Q4
$1.03M Buy
+9,900
New +$857K 0.05% 214

Other funds holding SWAV

Bailard's SWAV Position: Q4 2022 in Review

Bailard sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2022, closing a stake of 897 shares — an estimated $249K sold.

Bailard first reported a position in SWAV in Q4 2020 and held it in 2 quarters. The position peaked at $1.03M in Q4 2020. 415 funds tracked by Wall St. Rank hold SWAV as of Q4 2022.

  • Bailard reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Bailard sold 897 Shockwave Medical, Inc. Common Stock shares in Q4 2022, an estimated $249K.
  • Bailard first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Bailard's Shockwave Medical, Inc. Common Stock position peaked at $1.03M in Q4 2020.
  • 415 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2022.

Based on Bailard's 13F filing for Q4 2022, filed 2 Feb 2023.